Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
Lifeward Ltd. - Ordinary Shares (LFWD)
Company Research
Source: GlobeNewswire
Positions Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds the platform’s clinical development Provides Lifeward access to up to $47 million of capital HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that its shareholders approved the issuances of ordinary shares of the Company in connection with closing of the Company’s previously announced strategic partnership agreement with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP). “This is a defining moment in Lifeward’s evolution,” said Mark Grant, President and CEO of Lifeward. “With this partnership now moving towards closing, we believe Lifeward is uniquely pos
Show less
Read more
Impact Snapshot
Event Time:
LFWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFWD alerts
High impacting Lifeward Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LFWD
News
- Lifeward (LFWD) had its price target raised by HC Wainwright from $4.50 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Lifeward Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- Lifeward Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswire
- Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026GlobeNewswire
LFWD
Earnings
- 3/18/26 - Miss
LFWD
Sec Filings
- 3/18/26 - Form 10-K
- 3/18/26 - Form 8-K
- 3/13/26 - Form 8-K
- LFWD's page on the SEC website